what was the first glp-1 agonist Discovery of GLP-1–Based Drugs for Treatment of Obesity Emerging Trends in the Development
Description
Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial results.
Drug safety isnt just about innovation
Discover how GLP-1 medications help fatty liver disease through clinical evidence, FDA-approved options, patient selection criteria, and monitoring protocols for MASLD and NASH treatment.
In the subgroup analyses, human GLP-1 RAs, but not nonhuman GLP-1 RAs, reduced the risk of MACE in patients with HF (p interaction = 0.11)
